Condition · Brain, Mood & Sleep
Cognitive Performance / Focus
01
Evidence-ranked peptides
| Peptide | Use | Evidence |
|---|---|---|
| Semax Semax is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials. | Cognitive Performance / Focus insufficient | Human3/5 Animal2/5 Safety3/5 3 verified refs |
| Selank Selank is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials. | Cognitive Performance / Focus insufficient | Human3/5 Animal0/5 Safety3/5 3 verified refs |
| Angiotensin IV A short endogenous angiotensin fragment studied mainly for learning, memory, cerebral blood flow and insulin-regulated aminopeptidase biology. | Cognitive Performance / Focus insufficient | Human1/5 Animal0/5 Safety0/5 2 verified refs |
| Dihexa Dihexa is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials. | Cognitive Performance / Focus insufficient | Human0/5 Animal0/5 Safety0/5 0 verified refs |
| Pinealon Pinealon is an organ-associated short peptide promoted for regulatory effects, but independent modern clinical evidence is sparse. | Cognitive Performance / Focus insufficient | Human0/5 Animal0/5 Safety0/5 0 verified refs |
| Cerebrolysin Cerebrolysin is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials. | Cognitive Performance / Focus weak | Human0/5 Animal0/5 Safety0/5 0 verified refs |
| Galanin Galanin is an endogenous peptide with established physiological or receptor-level biology; therapeutic administration and indications are molecule-specific. | Cognitive Performance / Focus insufficient | Human0/5 Animal0/5 Safety0/5 0 verified refs |
| Orexin Orexin is an endogenous signalling peptide with physiological relevance; therapeutic administration remains molecule- and indication-specific. | Cognitive Performance / Focus insufficient | Human0/5 Animal0/5 Safety0/5 0 verified refs |
| NAP Peptide NAP Peptide is an investigational peptide, analogue or research construct with evidence ranging from mechanistic studies to limited human trials. | Cognitive Performance / Focus insufficient | Human0/5 Animal0/5 Safety0/5 0 verified refs |
02
Current standard management
conventional medicineEvidence-based non-peptide options — including exercise, sleep, nutrition, physiotherapy and licensed medical treatments — often have stronger human evidence than research peptides.
Medical disclaimer —Standard-of-care information is educational only. Do not change or start treatment based on Atlas content. Always consult a qualified clinician for personal medical decisions.
04
Linked mechanisms
biological pathways discussed for this condition- Neuroplasticityneeds review
- BDNF/neuronal signallingneeds review
- Cerebral metabolismneeds review
- Stress modulationneeds review
- Synaptic functionneeds review
- Neuroplasticitylimited
- Sleep homeostasis and neuropeptide signallinglimited
- Enkephalin and GABA-related anxiety signallinglimited
- Melanocortin and neurotrophic signallinglimited
- Inflammation modulationlimited
03
Community observations
No approved community reports for this condition yet. Submit one.
Clinician discussion
Questions you can ask a qualified clinician
- What are the established evidence-based options for this condition?
- What monitoring is appropriate before considering any experimental intervention?
- What long-term safety data exists for peptide-based approaches?
- Are there licensed medicines relevant to my situation?
↳
Explore further
from the knowledge graphPeptides that touch this